APNHY
Price
$5.45
Change
-$0.39 (-6.68%)
Updated
Sep 25 closing price
Capitalization
2.44B
PRFX
Price
$1.39
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
2.8M
45 days until earnings call
Interact to see
Advertisement

APNHY vs PRFX

Header iconAPNHY vs PRFX Comparison
Open Charts APNHY vs PRFXBanner chart's image
Aspen Pharmacare Holdings
Price$5.45
Change-$0.39 (-6.68%)
Volume$640
Capitalization2.44B
PainReform
Price$1.39
Change-$0.00 (-0.00%)
Volume$129.7K
Capitalization2.8M
APNHY vs PRFX Comparison Chart in %
Loading...
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APNHY vs. PRFX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APNHY is a Hold and PRFX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (APNHY: $5.45 vs. PRFX: $1.39)
Brand notoriety: APNHY and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: APNHY: 38% vs. PRFX: 3%
Market capitalization -- APNHY: $2.44B vs. PRFX: $2.8M
APNHY [@Pharmaceuticals: Generic] is valued at $2.44B. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $2.8M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.81B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APNHY’s FA Score shows that 1 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • APNHY’s FA Score: 1 green, 4 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, both APNHY and PRFX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APNHY’s TA Score shows that 4 TA indicator(s) are bullish while PRFX’s TA Score has 2 bullish TA indicator(s).

  • APNHY’s TA Score: 4 bullish, 4 bearish.
  • PRFX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, APNHY is a better buy in the short-term than PRFX.

Price Growth

APNHY (@Pharmaceuticals: Generic) experienced а -6.15% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was -6.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

PRFX is expected to report earnings on Nov 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APNHY($2.44B) has a higher market cap than PRFX($2.8M). APNHY YTD gains are higher at: -33.989 vs. PRFX (-58.569). PRFX has less debt than APNHY: PRFX (59K) vs APNHY (36.1B).
APNHYPRFXAPNHY / PRFX
Capitalization2.44B2.8M87,348%
EBITDA2.16BN/A-
Gain YTD-33.989-58.56958%
P/E Ratio10.28N/A-
Revenue43.4BN/A-
Total Cash6.41BN/A-
Total Debt36.1B59K61,186,441%
FUNDAMENTALS RATINGS
APNHY: Fundamental Ratings
APNHY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APNHYPRFX
RSI
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
55%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
67%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 7 days ago
68%
Bullish Trend 10 days ago
88%
Declines
ODDS (%)
Bearish Trend 12 days ago
57%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
57%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
47%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APNHY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LMBMX15.630.16
+1.03%
Franklin U.S. Small Cap Equity IS
AAASX12.480.10
+0.81%
DWS RREEF Real Assets S
AVDNX15.030.12
+0.80%
Avantis® International Equity G
AMEFX27.400.15
+0.55%
American Funds Income Fund of Amer F2
CFIGX14.610.05
+0.34%
Columbia Flexible Capital Income C

APNHY and

Correlation & Price change

A.I.dvisor tells us that APNHY and TEVA have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APNHY and TEVA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APNHY
1D Price
Change %
APNHY100%
N/A
TEVA - APNHY
23%
Poorly correlated
-0.11%
PRFX - APNHY
18%
Poorly correlated
N/A
QNTM - APNHY
17%
Poorly correlated
-4.39%
YCBD - APNHY
0%
Poorly correlated
+3.65%
ABSCF - APNHY
0%
Poorly correlated
N/A
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and BHC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and BHC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
N/A
BHC - PRFX
26%
Poorly correlated
+0.31%
AMRX - PRFX
24%
Poorly correlated
+1.56%
EVOK - PRFX
24%
Poorly correlated
-2.20%
ZTS - PRFX
22%
Poorly correlated
+1.68%
PBH - PRFX
21%
Poorly correlated
+0.40%
More